ZYNEZynerba Pharmaceuticals, Inc.

Nasdaq zynerba.com


$ 1.31 $ 0.03 (2.36 %)    

Tuesday, 10-Oct-2023 12:06:11 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 1.3
$ 1.27
$ 1.31 x 6,400
$ 1.32 x 700
$ 1.27 - $ 1.31
$ 0.25 - $ 1.40
862,786
na
65.2M
$ 0.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2023 06-30-2023 10-Q
2 05-15-2023 03-31-2023 10-Q
3 03-28-2023 12-31-2022 10-K
4 11-14-2022 09-30-2022 10-Q
5 08-10-2022 06-30-2022 10-Q
6 05-16-2022 03-31-2022 10-Q
7 03-01-2022 12-31-2021 10-K
8 11-15-2021 09-30-2021 10-Q
9 08-09-2021 06-30-2021 10-Q
10 05-12-2021 03-31-2021 10-Q
11 03-10-2021 12-31-2020 10-K
12 11-09-2020 09-30-2020 10-Q
13 08-10-2020 06-30-2020 10-Q
14 05-11-2020 03-31-2020 10-Q
15 03-10-2020 12-31-2019 10-K
16 11-06-2019 09-30-2019 10-Q
17 08-06-2019 06-30-2019 10-Q
18 05-08-2019 03-31-2019 10-Q
19 03-11-2019 12-31-2018 10-K
20 11-08-2018 09-30-2018 10-Q
21 08-02-2018 06-30-2018 10-Q
22 05-08-2018 03-31-2018 10-Q
23 03-12-2018 12-31-2017 10-K
24 11-14-2017 09-30-2017 10-Q
25 08-01-2017 06-30-2017 10-Q
26 05-09-2017 03-31-2017 10-Q
27 03-27-2017 12-31-2016 10-K
28 11-14-2016 09-30-2016 10-Q
29 08-11-2016 06-30-2016 10-Q
30 05-12-2016 03-31-2016 10-Q
31 03-14-2016 12-31-2015 10-K
32 11-12-2015 09-30-2015 10-Q
33 08-27-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 new-possibilities-for-cannabinoid-treatments-acquisition-to-transform-neuropsychiatric-disorder-therapies

Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba ...

Core News & Articles

 In connection with the previously announced merger agreement, Harmony Biosciences Holdings, Inc. ("Harmony") (NASDAQ:H...

Core News & Articles

GAINERS: Red White & Bloom Brands (OTC:RWBYF) shares closed up 300.00% at $0.04

 occidental-petroleum-to-rally-around-18-here-are-10-other-analyst-forecasts-for-wednesday

Piper Sandler lowered the price target for Riskified Ltd. (NYSE: RSKD) from $8 to $7. Piper Sandler analyst Brent Bracelin ...

 canaccord-genuity-downgrades-zynerba-pharmaceuticals-to-hold-lowers-price-target-to-111

Canaccord Genuity analyst Sumant Kulkarni downgrades Zynerba Pharmaceuticals (NASDAQ:ZYNE) from Buy to Hold and lowers the p...

 hc-wainwright--co-downgrades-zynerba-pharmaceuticals-to-neutral

HC Wainwright & Co. analyst Corey Davis downgrades Zynerba Pharmaceuticals (NASDAQ:ZYNE) from Buy to Neutral.

Core News & Articles

GAINERS: Choom Holdings (OTC:CHOOF) shares closed up 900.00% at $0.0001

 crude-oil-down-1-zynerba-pharmaceuticals-shares-spike-higher

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow trad...

 why-22nd-century-group-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into...

 us-stocks-turn-higher-bioxcel-therapeutics-shares-plummet

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 80 points on Monday. The ...

 why-zynerba-pharmaceuticals-stock-is-skyrocketing-today

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares are skyrocketing Monday after Harmony Biosciences (NASDAQ: HRMY) announced ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION